Point72 Hong Kong LTD Gossamer Bio, Inc. Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $95,402 - $196,892	13,232 New	13,232 $159,000
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $22,542 - $37,646	-3,776 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $31,869 - $47,162	3,776 New	3,776 $33,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $13,945 - $19,388	-1,378 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $9,990 - $18,230	1,378 New	1,378 $17,000
Q3 2020 Nov 16, 2020	SELL	$11.3 - $14.75 $60,534 - $79,015	-5,357 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $50,998 - $85,604	5,357 New	5,357 $70,000

116

163M

821K

557K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $115M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.